Mar 12, 2020 4:02pm EDT CohBar Reports Fourth Quarter 2019 Financial Results and Provides Business Update
Mar 02, 2020 4:30pm EST CohBar to Announce 2019 Fourth Quarter Financial Results and Provide Business Update on March 12, 2020
Jan 08, 2020 9:00am EST CohBar Discovers Novel Peptide Inhibitors of CXCR4, a Key Regulator of Tumor Growth and Metastasis
Dec 16, 2019 9:00am EST CohBar Confirms Anti-fibrotic Effect of a Novel Peptide in a Therapeutic Model of Idiopathic Pulmonary Fibrosis
Nov 05, 2019 9:00am EST CohBar Completes Phase 1a and Initiates Phase 1b Stage of Clinical Trial of CB4211 Under Development for NASH and Obesity
Oct 24, 2019 9:00am EDT CohBar to Announce 2019 Third Quarter Financial Results and Provide Business Update on November 6, 2019